Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
01/24/2022 01/25/2022 01/26/2022 01/27/2022 01/28/2022 Date
50(c) 50.82(c) 51.55(c) 52.58(c) 52.83(c) Last
4 413 530 3 264 976 2 686 001 3 124 651 3 338 588 Volume
-3.14% +1.64% +1.44% +2.00% +0.48% Change
More quotes
Estimated financial data (e)
Sales 2021 43 078 M 48 019 M 48 019 M
Net income 2021 459 M 511 M 511 M
Net Debt 2021 37 821 M 42 159 M 42 159 M
P/E ratio 2021 83,8x
Yield 2021 3,87%
Sales 2022 44 858 M 50 003 M 50 003 M
Net income 2022 4 582 M 5 108 M 5 108 M
Net Debt 2022 36 436 M 40 615 M 40 615 M
P/E ratio 2022 11,3x
Yield 2022 4,18%
Capitalization 51 901 M 57 932 M 57 855 M
EV / Sales 2021 2,08x
EV / Sales 2022 1,97x
Nbr of Employees 99 814
Free-Float 100,0%
More Financials
Company
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is... 
Sector
Pharmaceuticals
Calendar
02/16 | 08:00am
More about the company
Ratings of Bayer AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about BAYER AG
01/27Simbiose Agro acquired Biagro S.A. from Bayer Aktiengesellschaft.
CI
01/21MustGrow Biologics Up 7.6% after Reporting Exclusive Agreement with Bayer
MT
01/19BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patie..
AQ
01/17Factbox-GSK's consumer healthcare business coveted by Unilever
RE
01/17BAYER : Annual Bayer Pharma Media Day 2022
PU
01/15Factbox-GSK's consumer health business
RE
01/12BAYER AG : JP Morgan keeps its Buy rating
MD
01/11Netafim USA and Bayer Partners to Launch the “Precise Defense” Crop Protectio..
CI
01/10Correction to Bayer Gene Editing Article
DJ
01/10Bayer to Collaborate on Gene Editing Technology With Mammoth Biosciences
DJ
01/10Bayer in gene therapy collaboration with Mammoth Biosciences
RE
01/10Bayer Partners With Mammoth Biosciences To Develop Gene-Editing Therapies
MT
01/10Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology
CI
01/07Ex-Monsanto employee pleads guilty to corporate spying for China
AQ
01/07AVOIDING A TOXIC SITUATION : Lessons From Bard V. Monsanto
AQ
More news
News in other languages on BAYER AG
01/28Morning Briefing - International
01/27SIMBIOSE AGRO A RACHETÉ BIAGRO S.A. : Bayn).
01/26HAALAND GIBT NACH VERLETZUNG ENTWARN : 'Werde bald zurück sein'
01/26Credit Suisse verlaagt koersdoel Philips
01/25Bayer beteiligt sich an künftigem Hersteller von Zelltherapien
More news
Analyst Recommendations on BAYER AG
More recommendations
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | MarketScreener
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 52,83 €
Average target price 64,23 €
Spread / Average Target 21,6%
EPS Revisions
Managers and Directors
Werner Baumann Chairman-Management Board & CEO
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BAYER AG12.40%57 932
JOHNSON & JOHNSON0.42%452 254
ROCHE HOLDING AG-6.24%308 691
PFIZER, INC.-7.99%304 947
ABBVIE INC.1.86%243 826
ELI LILLY AND COMPANY-11.27%222 206